Betamethasone

CHEMBL632 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
392.5 g/mol
LogP
1.9
Phase
4

A potent synthetic corticosteroid that reduces inflammation and suppresses the immune system, used to treat a wide range of conditions including severe allergies, skin disorders, and inflammatory diseases. It is available in many formulations including creams, injections, and tablets. Long-term use carries risks of adrenal suppression and other systemic effects.

分子量

392.5000 g/mol

LogP

1.90

TPSA

94.80 Ų

リピンスキーの五則

適合

治療領域

作用機序

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

InChI

InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1

Molecular Formula

C22H29FO5

HBD / HBA

3 / 6

回転可能結合数

2

重原子数

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A potent synthetic corticosteroid that reduces inflammation and suppresses the immune system, used to treat a wide range of conditions including severe allergies, skin disorders, and inflammatory diseases. It is available in many formulations including creams, injections, and tablets. Long-term use carries risks of adrenal suppression and other systemic effects.

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

Yes, Betamethasone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL632. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9782. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.